Publications To Date


    Filter Publications


    Oberkampf M. et. al., 2018 Mitochondrial reactive oxygen species regulate the induction of CD8+ T cells by plasmacytoid dendritic cells,, Nature Commun., Jun 08, 2018

    Cheung P.F-Y. et. al., 2018 Notch-induced myeloid reprogramming in spontaneous pancreatic ductal adenocarcinoma by dual genetic targeting, .1158/0008-5472.CAN-18-0052, Cancer Res., May 29, 2018

    Chen M. et. al., 2018 JAK2 and PD-L1 amplification enhance the dynamic expression of PD-L1 in triple negative breast cancer,, Clin. Breast Can., May 26, 2018

    Noh K.W et. al., 2018 Integrin β3 inhibition enhances the antitumor activity of ALK inhibitor in ALK-rearranged NSCLC., 10.1158/1078-0432.CCR-17-3492. , Clin. Can Res., May 18, 2018

    Chettimada S. et. al., 2018 Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy,, Sci. Reports, May 08, 2018

    Zhang A.W. et. al., 2018 Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer., 10.1016/j.cell.2018.03.073., Cell, May 07, 2018

    Liu Z. et. al., 2018 Novel effector phenotype of Tim-3+ regulatory T cells leads to enhanced suppressive function in head and neck cancer patients., 10.1158/1078-0432.CCR-17-1350, Clin. Can. Res,, Apr 30, 2018

    Ganguly D. et. al., 2018 The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma, 10.18632/oncotarget.25188, Oncotarget, Apr 24, 2018

    Mu L. et. al., 2018 The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas, 10.3389/fnmol.2018.00082, Front. Mol. Neurosci., Mar 28, 2018

    Wielgos M.E. et. al., 2018 Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition., 10.1158/1535-7163.MCT-17-0302, Mol. Cancer. Ther., Mar 28, 2018

    Arend R.C. et. al., 2018 Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma., 10.1158/1541-7786.MCR-17-0594, Mol. Can. Res., Mar 08, 2018

    Nakazawa Y. et. al., Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer, 10.1038/s41598-018-22340-7, Sci. Reports, Mar 05, 2018

    Zamarin D. et. al., 2018 PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy, 10.1172/JCI98047 , JCI, Mar 05, 2018

    Sampath S. et. al., Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients, 10.18632/oncotarget.24397 , Oncotarget, Feb 02, 2018

    Daemen A. et. al., HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors, 10.1186/s13058-018-0933-y, Breast Can. Res., Jan 30, 2018